AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
NIQVX
Price
$14.79
Change
-$0.10 (-0.67%)
Updated
Oct 17 closing price
Net Assets
1.12B
Interact to see
Advertisement

AEPCX vs NIQVX

Header iconAEPCX vs NIQVX Comparison
Open Charts AEPCX vs NIQVXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.72B
Neuberger Berman International Eq I
Price$14.79
Change-$0.10 (-0.67%)
VolumeN/A
Net Assets1.12B
AEPCX vs NIQVX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. NIQVX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and NIQVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. NIQVX (1.12B). NIQVX pays higher dividends than AEPCX: NIQVX (1.39) vs AEPCX (0.16). AEPCX was incepted earlier than NIQVX: AEPCX (25 years) vs NIQVX (13 years). AEPCX (1.57) is less costly to investors than NIQVX (1.26). NIQVX is a more actively managed with annual turnover of: 64.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than NIQVX: AEPCX (250) vs NIQVX (1000). AEPCX annual gain was more profitable for investors over the last year : 10.02 vs. NIQVX (8.16). NIQVX (10.24) and AEPCX (9.92) have equivalent 5 years return.
AEPCXNIQVXAEPCX / NIQVX
Total Expense Ratio1.571.26125%
Annual Report Gross Expense Ratio1.571.26125%
Fund Existence25 years13 years-
Gain YTD20.63117.943115%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets138B1.12B12,355%
Annual Yield % from dividends0.161.3911%
Returns for 1 year10.028.16123%
Returns for 3 years45.8546.02100%
Returns for 5 years9.9210.2497%
Returns for 10 years36.7647.6077%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp